Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence by Erica Chilson, Daniel A. Scott, Beate Schmoele-Thoma, Wendy Watson, Mary M. Moran, Raul Isturiz

Connect to this object online.

Impact of COVID-19 and effects of BNT162b2 on patient-reported outcomes: quality of life, symptoms, and work productivity among US adult outpatients by Manuela Di Fusco, Xiaowu Sun, Mary M. Moran, Henriette Coetzer, Joann M. Zamparo, Laura Puzniak, Mary B. Alvarez, Ying P. Tabak, Joseph C. Cappelleri

Connect to this object online.

Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron by Manuela Di Fusco, Xiaowu Sun, Mary M. Moran, Henriette Coetzer, Joann M. Zamparo, Mary B. Alvarez, Laura Puzniak, Ying P. Tabak, Joseph C. Cappelleri

Connect to this object online.

Clinical outcomes of COVID-19 and influenza in hospitalized children <5 years in the US by Leah J. McGrath, Mary M. Moran, Tamuno Alfred, Maya Reimbaeva, Manuela Di Fusco, Farid Khan, Verna L. Welch, Deepa Malhotra, Alejandro Cane, Santiago M. C. Lopez

Connect to this object online.